KR20020014453A - Ultraviolet-protecting cosmetic composition containing Saxifragaceae extracts - Google Patents

Ultraviolet-protecting cosmetic composition containing Saxifragaceae extracts Download PDF

Info

Publication number
KR20020014453A
KR20020014453A KR1020000047747A KR20000047747A KR20020014453A KR 20020014453 A KR20020014453 A KR 20020014453A KR 1020000047747 A KR1020000047747 A KR 1020000047747A KR 20000047747 A KR20000047747 A KR 20000047747A KR 20020014453 A KR20020014453 A KR 20020014453A
Authority
KR
South Korea
Prior art keywords
extract
composition
sublingual
cell
saxifragaceae
Prior art date
Application number
KR1020000047747A
Other languages
Korean (ko)
Inventor
구본욱
이주동
진기홍
Original Assignee
김해관
엔프라니 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김해관, 엔프라니 주식회사 filed Critical 김해관
Priority to KR1020000047747A priority Critical patent/KR20020014453A/en
Publication of KR20020014453A publication Critical patent/KR20020014453A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE: Provided is a skin care cosmetic composition for blocking UV containing Saxifragaceae extract. It activates DNA repairing enzyme system in vivo thus inhibits the mutation of a skin cell caused by DNA damage by UV and has a UV blocking effect. CONSTITUTION: The composition comprises 0.1-60, preferably 0.1-25 wt.% of Saxifragaceae extract having a bio-anti-mutagen, to the total weight of the composition, wherein the extract comprises tannin derivative and terpin essential oil as a bio-anti-mutagen, and is preferably extracted by the steps of: finely cutting 10kg of Saxifragaceae; adding 30 volume % of polyol; then extracting and filtering it.

Description

설하 추출물을 함유하는 자외선 방어용 피부화장료 조성물{Ultraviolet-protecting cosmetic composition containing Saxifragaceae extracts}Ultraviolet-protecting cosmetic composition containing Saxifragaceae extracts}

본 발명은 설하 추출물(雪下;Saxifragaceae)을 함유하는 자외선 방어용 피부화장료 조성물에 관한 것으로서, 보다 상세하게는, 전체 조성물 중량 대비 0.1∼60중량%의 설하 추출물을 함유함으로써, 생체내 DNA 복구효소 시스템을 활성화시켜 자외선에 의해 유발되는 DNA 손상에 의한 피부세포 변이를 억제하여 자외선 방어효과를 갖는 피부화장료 조성물에 관한 것이다.The present invention relates to a UV protective skin cosmetic composition containing a sublingual extract (雪 x; Saxifragaceae ), more specifically, in vivo DNA repair enzyme system by containing a sublingual extract of 0.1 to 60% by weight of the total composition It relates to a skin cosmetic composition having a UV protective effect by inhibiting skin cell mutations caused by DNA damage caused by ultraviolet rays.

자외선이 피부에 유해하다는 사실은 잘 알려져 있다. 일반적으로, 자외선이 피부에서 멜라닌 형성과 활성효소 및 단백질 변성에 영향을 미쳐 노화(광노화)를 일으키는 메카니즘에 대해서는 많은 연구가 이루어져 왔다. 반면, 자외선이 피부에 미치는 가장 심각한 영향인 DNA 손상과 피부세포 변이에 대한 연구는 제대로 이루어지지 않아, 자외선을 방어하기 위한 방법은 자외선 차단제를 함유하는 조성물을 이용하는 것에 국한되어 왔다. 그러나, 피부암의 원인이 자외선에 의해 유발되는 DNA 손상이라는 연구가 전개됨에 따라, DNA 손상이 광노화에 미치는 영향뿐만아니라 피부암 증가에 미치는 영향에 대한 관심이 급증하고 있다.It is well known that ultraviolet radiation is harmful to the skin. In general, much research has been done on the mechanism by which ultraviolet light affects melanin formation and active enzyme and protein denaturation in the skin and causes aging (photoaging). On the other hand, studies on DNA damage and skin cell mutations, which are the most serious effects of ultraviolet rays on the skin, have not been conducted properly, so the method for protecting against ultraviolet rays has been limited to using a composition containing a sunscreen. However, as the research on the cause of skin cancer caused by DNA damage caused by ultraviolet light has been developed, interest in not only the effect of DNA damage on photoaging but also on the increase of skin cancer is rapidly increasing.

자외선이 피부에서 DNA 손상을 유발하는 메카니즘은 자외선이 직접적으로 DNA를 손상시키거나, 간접적으로 효소를 활성화시키는 것으로 요약될 수 있다. 이러한 DNA 손상은 DNA 염기중의 하나인 피리미딘(pyrimidine)이 이중합체나 6-4 축합체로 변형되거나, 자외선 에너지에 의해 DNA가 분열되는 것을 의미한다. 이때, DNA 손상이 매우 커서 생체가 자체적으로 갖는 DNA 복구(repair) 시스템으로 회복시키지 못하면 DNA 염기서열의 변이가 일어난다. 이러한 변이는 비정상적인 단백질 합성이나 세포 괴사를 유발한다. 따라서, 피부세포에서의 DNA 변이는 광노화 및 피부암과 밀접한 관련을 갖고 있다.The mechanism by which ultraviolet light causes DNA damage in the skin can be summarized as ultraviolet light directly damages DNA or indirectly activates enzymes. This DNA damage means that pyrimidine, one of the DNA bases, is transformed into an oligomer or 6-4 condensate, or the DNA is cleaved by ultraviolet energy. At this time, if DNA damage is very large and the body fails to recover its own DNA repair (repair) system, a DNA sequence mutation occurs. These mutations cause abnormal protein synthesis or cell necrosis. Thus, DNA mutations in skin cells are closely associated with photoaging and skin cancer.

자외선을 비롯한 세포 변이 유발 인자를 방어하는 물질을 두 종류로 나눌 수 있는데, 하나는 데스뮤타젠(desmutagen)으로서 세포 변이 유발 인자에 화학적, 효소적 또는 물리적으로 직접 작용하여 세포 변이 유발 인자를 불활성화시킨다. 자외선이 세포 변이 유발 인자인 경우에는, 멜라닌, 수퍼옥사이드 디스뮤타제(SOD), 자외선 차단제 등이 여기에 속한다. 다른 하나는 바이오-안티-뮤타젠(bio-anti-mutagen)으로서 손상된 세포에 작용하여 변이를 억제하는데, 그 메카니즘은 DNA 복구효소 시스템을 활성화시켜 DNA 복구를 촉진하는 것으로 추정된다. 바이오-안티-뮤타젠이 데스뮤타젠 보다 여러 종류의 세포 변이 유발 인자에 적용될 수 있다.There are two types of substances that can protect against cell-induced mutagens, including UV rays. One is desmutagen, which acts chemically, enzymatically or physically directly on cell-induced mutagens and inactivates them. Let's do it. When ultraviolet light is a cell mutagenesis factor, melanin, superoxide dismutase (SOD), a sunscreen, etc. belong to this. The other is bio-anti-mutagen, which acts on damaged cells to inhibit mutations, which is believed to activate DNA repair enzyme systems to promote DNA repair. Bio-anti-mutagen can be applied to a variety of cell mutation triggers than desmutagen.

이러한 자외선에 의한 DNA 변이를 방지하기 위하여 바이오-안티-뮤타젠을 함유하는 화장료 조성물에 대한 연구가 시작되었으며, 특히 소비자들의 욕구에 부응하기 위하여 천연 원료를 이용한 화장료 조성물에 대한 연구·개발이 활발히 진행되고 있는 추세이다.In order to prevent DNA mutations caused by UV rays, research on cosmetic compositions containing bio-anti-mutagen has begun. In particular, research and development on cosmetic compositions using natural raw materials are actively conducted to meet the needs of consumers. It is becoming a trend.

한편, 설하는 중국에서는 타이거 이어(tiger ear)라고 불리는 것으로서, 오래전부터 주로 접촉성 피부염, 화상, 동상 등의 치료에 이용되어 왔으며, 항염제로도 이용되어 왔다.On the other hand, the tongue is called the tiger ear in China, has been used for a long time mainly for the treatment of contact dermatitis, burns, frostbite, etc., and has also been used as an anti-inflammatory agent.

이에, 본 발명자들은 자외선에 의해 유발되는, 광노화와 피부암의 원인이 되는 DNA 손상에 의한 피부세포 변이를 억제하는 효과를 갖는, 기존의 자외선 차단제 함유 조성물과는 다른 형태의 자외선 방어용 화장료 조성물을 개발하기 위하여 지속적인 연구를 수행하였다. 그 결과, 설하 추출물을 적절히 배합하여 제조한 본 발명의 조성물이 현저히 향상된 DNA 손상 억제효과와 손상된 DNA 복구효과를 나타낸다는 놀라운 사실을 발견하고, 본 발명을 완성하였다.Accordingly, the present inventors have developed an ultraviolet protective cosmetic composition different from the existing sunscreen containing composition, which has an effect of inhibiting skin cell variation caused by ultraviolet rays, caused by photoaging and DNA damage causing skin cancer. Continuous studies were conducted for this purpose. As a result, the present inventors have found a surprising fact that the composition of the present invention prepared by appropriately blending sublingual extracts exhibits significantly improved DNA damage suppressing effect and damaged DNA repair effect, and completed the present invention.

따라서, 본 발명의 목적은 설하 추출물을 함유함으로써, 생체내 DNA 복구효소 시스템을 활성화시켜 자외선에 의해 유발되는 DNA 손상에 의한 피부세포 변이를 억제하여, 궁극적으로는 광노화와 피부암을 억제할 수 있는 자외선 방어용 피부화장료 조성물을 제공하기 위한 것이다.Accordingly, an object of the present invention is to contain a sublingual extract, thereby activating the DNA repair enzyme system in vivo to suppress skin cell mutations caused by DNA damage caused by ultraviolet light, ultimately to inhibit photoaging and skin cancer It is to provide a protective skin cosmetic composition.

본 발명은 전체 조성물 중량 대비 0.1∼60중량%의 설하 추출물을 함유하는 자외선 방어용 피부화장료 조성물을 제공한다. 본 발명에 따른 조성물은 생체내 DNA 복구효소 시스템을 활성화시켜 자외선에 의해 유발되는 DNA 손상에 의한 피부세포 변이를 억제할 수 있다. 본 조성물에 있어서, 설하 추출물은 탄닌(tannin)유도체 및 터핀 에센스 오일(terpin essential oil)을 함유하는 것이 바람직하고, 세절된 설하를 폴리올(polyol)로 추출하여 얻어지는 것이 바람직하다. 또한, 전체 조성물 중량 대비 0.1∼25중량%의 설하 추출물을 함유하는 것이 보다 바람직하다.The present invention provides a UV protective skin cosmetic composition containing a sublingual extract of 0.1 to 60% by weight based on the total weight of the composition. The composition according to the present invention can activate the DNA repair enzyme system in vivo to inhibit skin cell mutation caused by DNA damage caused by ultraviolet light. In the present composition, the sublingual extract preferably contains tannin derivatives and terpin essential oils, and it is preferable that the sublingual extract is obtained by extracting fine sublingually with a polyol. Further, it is more preferable to contain 0.1 to 25% by weight of sublingual extract relative to the total composition weight.

이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

본 발명의 조성물에 있어서, 설하 추출물은 설하로부터 추출하여 정제된 탄닌 유도체(예를들어, 프로안토시아니딘)와 터핀 에센스 오일(예를들어, 리프 알콜(leaf alcohol), 캄펜(camphene), 리날롤(linalool), 보르네올(borneol) 등)을 함유하는 것이다. 즉, 세절된 설하에 적당한 추출용매, 바람직하게는, 폴리올을 적당량, 바람직하게는, 30부피%가 되도록 첨가하고 추출·여과하여 최종 추출액을 얻는다. 본 발명에서는 설하 추출물로서 예를들어, 시판중인 상품명 유키노시타 리퀴드-MB(Yukinoshita Liquid-MB; Ichimaru Pharcos Co., Ltd. 제조)를 사용할 수 있다.In the composition of the present invention, the sublingual extract is extracted from sublingually purified tannin derivatives (e.g., proanthocyanidins) and terpin essence oils (e.g., leaf alcohols, camphene, Linalool, borneol, and the like). In other words, an appropriate extraction solvent, preferably a polyol, is added to an appropriate amount, preferably 30% by volume, and the resultant is extracted and filtered under a subdivided tongue to obtain a final extract. In the present invention, as the sublingual extract, for example, commercially available Yukinoshita Liquid-MB (manufactured by Ichimaru Pharcos Co., Ltd.) can be used.

본 발명에서, 설하 추출물은 자외선에 의한 DNA 손상을 억제하는 작용을 한다. 보다 구체적으로 설명하면, 자외선에 의한 DNA 유전정보의 손상은 DNA 염기서열의 변화를 일으키거나 세포의 괴사를 일으킨다. DNA의 염기서열이 변화하면 곧 변이가 일어난다. 이러한 DNA 유전정보의 변화와 세포 괴사를 방지하기 위하여 세포 자체내에는 DNA 복구효소 시스템이 존재한다. 이러한 시스템의 활성을 높여주는 물질을 바이오-안티-뮤타젠이라 한다. 본 발명의 조성물은 피부에 대한 설하 추출물의 작용에 의해 자외선에 의한 DNA 손상 등의 피해를 감소시켜 자외선에 대한 피부 방어효과를 발휘할 수 있다.In the present invention, the sublingual extract acts to inhibit DNA damage by ultraviolet rays. More specifically, the damage of DNA genetic information by ultraviolet light causes a change in DNA sequence or necrosis of cells. As soon as the DNA sequence changes, a mutation occurs. In order to prevent such changes in DNA genetic information and cell necrosis, a DNA repair enzyme system exists in the cell itself. The substance that enhances the activity of this system is called bio-anti-mutagen. The composition of the present invention can exert a skin protective effect against ultraviolet rays by reducing damage such as DNA damage by ultraviolet rays by the action of the sublingual extract on the skin.

본 발명에 있어서, 자외선에 의한 DNA 손상을 억제하는 바이오-안티-뮤타젠의 효과는 자외선 조사후 발생하는 세포의 괴사 억제정도와 세포 변이의 억제정도를 측정함으로써 평가한다. 보다 구체적으로는, 세포 괴사 억제정도는 자외선 조사후 대장균(E. Coli)의 생존율로써, 세포 변이 억제정도는 변이 세포 발생율로써 측정한다. 대장균을 이용하는 이유는 대장균과 포유류에서 DNA 복구효소는 다르더라도 바이오-안티-뮤타젠과 같이 DNA 복구를 촉진하는 물질의 효과는 동일한 것으로 보고되었기 때문이다. 이때, 대장균의 한 종을 자외선 유발 변이의 검출에 적합하도록 개종하여 사용한다. 이 대장균 종은 자외선 조사 없이는 필수 아미노산인 트립토판을 생산하지 못하므로, 트립토판-결핍 배지에서는 생장하지 못하나, 자외선에 의해 변이된 대장균은 트립토판을 생산해내고 트립토판-결핍 배지에서도 생장한다. 즉, 생장을 위해 트립토판을 필요로 하는 대장균이 자외선에 의해 스스로 트립토판을 생산해낼 수 있도록 변이를 일으켜 트립토판 없이도 생장할 수 있는 현상을 이용하여, 대장균의 세포 변이 발생율을 측정한다. 세포 변이 억제효과는 세포 변이 발생율이 저하하고 자외선에 의한 살균효과(DNA 손상 인자)가 감소하여 결국 세포 생존율이 증가하는 정도로써 평가된다. 본 발명에서, 트립토판-의존성 대장균은 3가지 그룹으로 실험되는데, 첫째, 자외선만 조사하는 그룹, 둘째, 자외선 조사후 설하 추출물을 첨가하는 그룹, 셋째, 자외선도 조사하지 않고 설하 추출물도 첨가하지 않는 그룹이다. 각 그룹에서 세포 변이 대장균과 정상 대장균의 수를 결정한다.In the present invention, the effect of bio-anti-mutagen that inhibits DNA damage by ultraviolet rays is evaluated by measuring the degree of suppression of necrosis of cells and the degree of inhibition of cell variation that occur after ultraviolet irradiation. More specifically, the degree of inhibition of cell necrosis is measured by the survival rate of E. Coli after UV irradiation, and the degree of inhibition of cell mutation is measured by the rate of mutant cell generation. The reason for using E. coli is that even though DNA repair enzymes are different in E. coli and mammals, the effects of substances that promote DNA repair, such as bio-anti-mutagen, have been reported to be the same. At this time, one species of E. coli is converted and used so as to be suitable for detection of UV-induced mutations. This E. coli species does not produce tryptophan, an essential amino acid, without UV irradiation, so it does not grow on tryptophan-deficient media, but E. coli mutated by UV produces tryptophan and also on tryptophan-deficient media. In other words, E. coli, which requires tryptophan for growth, uses mutations that can be produced without tryptophan by causing mutations to produce tryptophan by ultraviolet rays, thereby measuring the incidence of cell mutations in E. coli. The effect of inhibiting cell mutation is evaluated as the extent to which cell incidence decreases and the bactericidal effect of ultraviolet light (DNA damage factor) decreases, thereby increasing cell survival rate. In the present invention, tryptophan-dependent E. coli is tested in three groups, first, the group irradiating only ultraviolet light, second, the group to add sublingual extract after ultraviolet irradiation, third, the group not to irradiate ultraviolet rays and do not add sublingual extract to be. Determine the number of cell variants in E. coli and normal E. coli in each group.

한편, 본 발명 조성물의 특징적인 구성성분인 설하 추출물의 배합량은 화장료 조성물의 종류에 따라 적절히 조정될 수 있으나, 바람직하게는 통상 전체 화장료 조성물 중량 대비 0.1∼60중량%, 보다 바람직하게는 0.1∼25중량%, 가장 바람직하게는 25중량%로 배합된다. 설하 추출물이 0.1중량% 미만으로 배합되면 DNA 손상 억제효과가 미미하며, 60중량%, 특히 25중량% 초과로 배합되어도 그 효과가 그다지 증가되지 않기 때문이다.On the other hand, the amount of the sublingual extract, which is a characteristic component of the composition of the present invention can be appropriately adjusted according to the type of cosmetic composition, but preferably 0.1 to 60% by weight, more preferably 0.1 to 25% by weight relative to the total cosmetic composition %, Most preferably 25% by weight. If sublingual extract is less than 0.1% by weight of the DNA damage inhibitory effect is minimal, even if it is blended in more than 60% by weight, especially more than 25% by weight because the effect is not so increased.

본 발명의 화장료 조성물에는 설하 추출물 이외에도 본 발명의 효과를 저해하지 않는 범위내에서 유성 기제, 계면활성제, 자외선 차단제, 산화방지제, 방부제, 향료, 색소, pH 조정제 등을 적정량 배합할 수 있다.In addition to the sublingual extract, the cosmetic composition of the present invention may be formulated with an appropriate amount of an oily base, a surfactant, a sunscreen, an antioxidant, a preservative, a perfume, a dye, a pH adjuster, and the like within a range that does not impair the effects of the present invention.

[실시예]EXAMPLE

이하, 본 발명을 실시예, 비교예 및 실험예를 통하여 보다 상세히 설명하나, 본 발명의 범위가 하기 실시예로 한정되는 것은 아니다. 하기 실시예에서 사용된 설하 추출물은 하기 제품을 사용하였다.Hereinafter, the present invention will be described in more detail with reference to Examples, Comparative Examples and Experimental Examples, but the scope of the present invention is not limited to the following Examples. The sublingual extract used in the following examples used the following products.

(설하 추출물)(Sublingual extract)

1. 추출법1. Extraction Method

(1) 설하 10 kg을 세절한다.(1) Cut 10 kg of sublingually.

(2) 30부피%가 되도록 폴리올을 첨가한다.(2) Polyol is added to 30 vol%.

(3) 추출·여과하여 최종 추출액을 얻는다.(3) Extraction and filtration obtain final extract.

2. 업체명: 이치마루(Ichimaru) Pharcos Co., Ltd.2. Company name: Ichimaru Pharcos Co., Ltd.

3. 상품명: 유키노시타 리퀴드-MB3. Product Name: Yukinoshita Liquid-MB

4. 조성: 탄닌 유도체, 터핀(leaf alcohol, camphene, linalool, borneol)4. Composition: Tannin derivatives, terpines (leaf alcohol, camphene, linalool, borneol)

[실시예 1~16 및 비교예] 크림의 제조Examples 1-16 and Comparative Examples Preparation of Cream

하기 표 1에 나타낸 조성(설하 추출물 제외)으로 유상성분과 수상성분을 각각 완전히 용해시키고 유화부에서 유화시켜 냉각시켰다.To the composition (except sublingual extract) shown in Table 1, the oil phase component and the water phase component were completely dissolved, respectively, and emulsified in the emulsifying unit and cooled.

성분명Ingredient Name 함량content 설하 추출물Sublingual extract 표 2에 기재된 양The amount listed in Table 2 백당지방산에스테르White sugar fatty acid ester 1.01.0 메틸파라벤Methylparaben 0.150.15 이미다졸리디닐우레아Imidazolidinylurea 0.20.2 글리세린glycerin 7.07.0 카보머Carbomer 0.150.15 소르비탄 모노스테아레이트Sorbitan monostearate 1.81.8 데카글리세릴 미리스테이트Decaglyceryl Myristate 1.21.2 글리세릴 모노스테아레이트Glyceryl Monostearate 2.02.0 세토스테아릴 알콜Cetostearyl alcohol 2.02.0 밀납Beeswax 1.01.0 세레신Ceresin 1.01.0 프로필파라벤Propylparaben 0.10.1 유동파라핀Liquid paraffin 3.03.0 카프릭/카프릴릭 트리글리세라이드Capric / Caprylic Triglycerides 17.017.0 스쿠알란Squalane 5.05.0 메틸폴리실록산Methylpolysiloxane 0.50.5 정제수Purified water 100까지Up to 100

40℃까지 냉각시킨후, 하기 표 2에 나타낸 함량으로 설하 추출물을 첨가하여 크림을 제조하였다.After cooling to 40 ° C., sublingual extract was added to the content shown in Table 2 below to prepare a cream.

실시예/비교예Example / Comparative Example 설하 추출물의 함량Sublingual Extract 실시예/비교예Example / Comparative Example 설하추출물의 함량Sublingual Extract Content 비교예Comparative example -- 실시예 9Example 9 20.020.0 실시예 1Example 1 0.10.1 실시예 10Example 10 25.025.0 실시예 2Example 2 1.01.0 실시예 11Example 11 30.030.0 실시예 3Example 3 2.02.0 실시예 12Example 12 35.035.0 실시예 4Example 4 3.03.0 실시예 13Example 13 40.040.0 실시예 5Example 5 5.05.0 실시예 14Example 14 45.045.0 실시예 6Example 6 7.07.0 실시예 15Example 15 50.050.0 실시예 7Example 7 10.010.0 실시예 16Example 16 55.055.0 실시예 8Example 8 15.015.0

[실험예] 자외선에 의한 DNA 손상 억제시험Experimental Example Inhibition of DNA Damage by UV Light

실험 시료: 유키노시타 리퀴드-MB(설하의 30부피% 폴리올 추출물)Test Sample: Yukinoshita Liquid-MB (30 vol% Polyol Extract in Sublingual)

균주:Escherichia coliB/r W2 트립토판(IFO 14195)Strain: Escherichia coli B / r W2 tryptophan (IFO 14195)

배지:badge:

B-2 액체 배지- 소 추출물과 폴리펩틴으로 구성된 균주 증식용 배지B-2 Liquid Medium- A medium for strain propagation consisting of bovine extracts and polypeptides

B-2 아가 배지- B-2 액체 배지에 아가를 첨가한 배지B-2 Agar Medium-Medium added agar to B-2 liquid medium

SEM 아가 배지- 트립토판-의존성 균주가 증식하지 못하도록 최소한의 글루코스 아가에 0.008% 영양액을 첨가한 배지SEM agar medium-medium supplemented with 0.008% nutrient solution to minimal glucose agar to prevent the growth of tryptophan-dependent strains

실험방법:Experimental method:

B-2 액체 배지에서 37℃, 15시간동안 조직 배양한 세포로부터 원심분리기로 배지를 제거한 후, 인산나트륨 완충액 100mM에 현탁시켰다. 현탁액의 탁도를 광학 밀도로 측정하고, 200∼300×503/0.1㎖ 세포 농도로 희석시켜 세포 현탁액으로 사용하였다. 세포 현탁액으로부터 20㎖을 살균된 용기에 취한후, 48J/㎡의 자외선을 용기에 조사하였다. 자외선 조사한 세포 현탁액 0.1㎖에 실험 시료 0.1㎖ 및 인산나트륨 0.5㎖을 첨가하였다. 세포 현탁액을 37℃에서 30분동안 충분히 흔든후, 두 그룹으로 나누었다. 한 그룹은 503 세포 밀도로 희석시키고 세포수를 측정하기 위해 B-2 아가 배지에 부드러운 아가를 첨가하며 배양하였다. 37℃에서 24시간 경과후 균체수를 측정하여 생존 세포수로 간주하였다. 다른 그룹은 부드러운 아가와 함께 SEM 배지에서 배양하고 37℃에서 48시간 경과후 균체수를 측정하여 변이 세포수로 간주하였다.The medium was removed by centrifugation from cells cultured for 15 hours at 37 ° C. in B-2 liquid medium, and then suspended in 100 mM sodium phosphate buffer. The turbidity of the suspension was measured by optical density and diluted to 200-300 x 503 / 0.1 ml cell concentration to use as cell suspension. 20 ml of the cell suspension was taken into a sterile container, and then 48 J / m 2 ultraviolet light was irradiated to the container. 0.1 ml of the test sample and 0.5 ml of sodium phosphate were added to 0.1 ml of the cell suspension irradiated with ultraviolet light. The cell suspension was sufficiently shaken at 37 ° C. for 30 minutes and then divided into two groups. One group was incubated with gentle agar added to B-2 agar medium to dilute to 503 cell density and measure cell number. After 24 hours at 37 ° C., the number of cells was measured and considered as viable cell number. The other group was cultured in SEM medium with gentle agar and after 48 hours at 37 ° C., the number of cells was measured and considered as the mutant cell number.

세포 변이 억제효과 측정방법:To measure the effect of inhibiting cell mutations:

세포 변이 억제효과를 자외선-조사된 세포의 생존율과 변이 발생율로 평가하였다. 자외선 조사전의 생존 세포수를 생존율 100%로 하고, 변이 발생율을 생존 세포수와 변이 세포수로 계산하며, 자외선 조사후 용매만 첨가한 그룹의 변이 발생율을 100%로 하였다.Inhibition of cell mutation was assessed by the survival and mutation incidence of UV-irradiated cells. The viable cell number before UV irradiation was calculated as 100% survival rate, and the incidence of mutation was calculated as the viable cell number and the mutant cell number.

세 그룹(① 자외선 조사 그룹, ② 자외선 조사 + 실험시료 처리 그룹, ③ 대조 그룹)에서 B-2 배지에서 측정된 세포 생존율은 각각 S1, S2, S3이고, SEM 배지에서 측정된 세포 변이율은 각각 T1, T2, T3이다.In three groups (① UV irradiation group, ② UV irradiation + test sample treatment group, ③ control group), cell survival rates measured in B-2 medium were S1, S2, and S3, respectively. T1, T2, and T3.

생존율(%) = S2 / S3 ×100 (%)Survival Rate (%) = S2 / S3 × 100 (%)

세포 변이 발생 빈도 = (T1 - T3) / S1 = M1Frequency of cell mutations = (T1-T3) / S1 = M1

세포 변이 발생율 = M2 / M1 ×100 (%)Incidence of cell mutation = M2 / M1 × 100 (%)

실험결과:Experiment result:

하기 표 3에 나타낸 바와 같이, 자외선에 의한 세포 변이 발생율은 유키노시타 리퀴드 MB의 함량에 따라 비례적으로 감소하였으며, 세포 생존율 또한 유키노시타 리퀴드 MB의 함량에 따라 증가하였다.As shown in Table 3 below, the incidence of cell mutation due to ultraviolet rays decreased proportionally with the content of Yukinoshita Liquid MB, and the cell viability also increased with the content of Yukinoshita Liquid MB.

UV 조사한 트립토판-의존성 대장균의 증식실험Growth test of tryptophan-dependent E. coli 실험 시료An experimental sample UVUV 생존율(%)Survival rate (%) 변이 빈도Variation frequency 변이 발생율(%)% Variation 억제율(%)% Inhibition 30% 1,3-BG30% 1,3-BG XX 100100 -- -- -- 30% 1,3-BG30% 1,3-BG OO 31.031.0 4.724.72 100100 -- 비교예Comparative example OO 30.930.9 4.704.70 100100 -- 실시예 1Example 1 OO 9.29.2 5.555.55 99.599.5 0.50.5 실시예 2Example 2 OO 47.947.9 3.203.20 90.490.4 9.69.6 실시예 3Example 3 OO 49.149.1 2.932.93 85.885.8 14.214.2 실시예 4Example 4 OO 49.749.7 2.742.74 72.872.8 27.227.2 실시예 5Example 5 OO 51.051.0 2.542.54 63.763.7 36.336.3 실시예 6Example 6 OO 51.151.1 2.202.20 59.359.3 40.740.7 실시예 7Example 7 OO 52.052.0 1.891.89 47.047.0 53.053.0 실시예 8Example 8 OO 52.552.5 1.421.42 35.035.0 65.065.0 실시예 9Example 9 OO 53.353.3 1.271.27 26.026.0 74.074.0 실시예 10Example 10 OO 55.555.5 1.141.14 24.224.2 75.875.8 실시예 11Example 11 OO 55.555.5 1.121.12 23.723.7 76.376.3 실시예 12Example 12 OO 55.555.5 1.101.10 22.522.5 77.577.5 실시예 13Example 13 OO 55.555.5 1.051.05 21.921.9 78.178.1 실시예 14Example 14 OO 55.555.5 1.021.02 21.521.5 78.578.5 실시예 15Example 15 OO 55.555.5 0.980.98 20.820.8 79.279.2 실시예 16Example 16 OO 55.555.5 0.950.95 20.520.5 79.579.5

* O: UV 조사함, X: UV 조사안함* O: No UV irradiation, X: No UV irradiation

상기 표 3에 나타낸 바와 같이, 유키노시타 리퀴드 MB는 바이오-안티-뮤타젠의 하나로 유해 자외선의 독성을 감소시키며, 25중량%로 사용하였을 때(실시예 10) 가장 유효한 효과를 나타내었다.As shown in Table 3, Yukinoshita Liquid MB is one of the bio-anti-mutagen to reduce the toxicity of harmful ultraviolet rays, when used at 25% by weight (Example 10) showed the most effective effect.

본 발명에 따른 화장료 조성물은 설하 추출물을 0.1∼60% 중량로 함유함으로써 자외선에 의한 피부세포 DNA 공격에 대해 우수한 방어효과를 나타낸다.The cosmetic composition according to the present invention exhibits an excellent protective effect against skin cell DNA attack by ultraviolet rays by containing 0.1 to 60% by weight of sublingual extract.

Claims (5)

전체 조성물 중량 대비 0.1∼60중량%의 설하(雪下;Saxifragaceae) 추출물을 함유하는 자외선 방어용 피부화장료 조성물.UV-protective skin cosmetic composition containing 0.1 to 60% by weight of sublingual ( Saxifragaceae ) extract based on the total weight of the composition. 제 1 항에 있어서, 생체내 DNA 복구효소 시스템을 활성화하여 자외선에 의해 유발되는 DNA 손상에 의한 피부세포 변이를 억제하는 조성물.The composition of claim 1, wherein the composition activates the DNA repair enzyme system in vivo to inhibit skin cell variation caused by UV damage-induced DNA damage. 제 1 또는 2 항에 있어서, 설하 추출물이 탄닌 유도체와 터핀 에센스 오일을 함유하는 조성물.The composition of claim 1 or 2, wherein the sublingual extract contains tannin derivatives and terpine essence oils. 제 1 또는 2 항에 있어서, 설하 추출물이 세절된 설하를 폴리올로 추출하여 얻어지는 것인 조성물.The composition according to claim 1 or 2, wherein the sublingual extract is obtained by extracting the subcutaneous sublingually with a polyol. 제 1 또는 2 항에 있어서, 전체 조성물 중량 대비 0.1∼25중량%의 설하 추출물을 함유하는 조성물.The composition according to claim 1 or 2, which contains 0.1 to 25% by weight of sublingual extract, based on the total weight of the composition.
KR1020000047747A 2000-08-18 2000-08-18 Ultraviolet-protecting cosmetic composition containing Saxifragaceae extracts KR20020014453A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020000047747A KR20020014453A (en) 2000-08-18 2000-08-18 Ultraviolet-protecting cosmetic composition containing Saxifragaceae extracts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020000047747A KR20020014453A (en) 2000-08-18 2000-08-18 Ultraviolet-protecting cosmetic composition containing Saxifragaceae extracts

Publications (1)

Publication Number Publication Date
KR20020014453A true KR20020014453A (en) 2002-02-25

Family

ID=19683733

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020000047747A KR20020014453A (en) 2000-08-18 2000-08-18 Ultraviolet-protecting cosmetic composition containing Saxifragaceae extracts

Country Status (1)

Country Link
KR (1) KR20020014453A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100999958B1 (en) * 2008-06-19 2010-12-09 주식회사 한국화장품제조 A cosmetic composition comprising an extract of Saxifraga caespitosa and a fabrication method of an extract of Saxifraga caespitosa

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02231427A (en) * 1989-03-03 1990-09-13 Ichimaru Pharcos Co Ltd Antimutagenic substance originated from saxifraga stolonifera
JPH0558870A (en) * 1991-08-27 1993-03-09 Suntory Ltd Beautifying and whitening composition
JPH10298026A (en) * 1997-04-25 1998-11-10 Kanebo Ltd Pack material
JPH1129460A (en) * 1997-07-04 1999-02-02 Pola Chem Ind Inc Cosmetic for sensitive skin

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02231427A (en) * 1989-03-03 1990-09-13 Ichimaru Pharcos Co Ltd Antimutagenic substance originated from saxifraga stolonifera
JPH0558870A (en) * 1991-08-27 1993-03-09 Suntory Ltd Beautifying and whitening composition
JPH10298026A (en) * 1997-04-25 1998-11-10 Kanebo Ltd Pack material
JPH1129460A (en) * 1997-07-04 1999-02-02 Pola Chem Ind Inc Cosmetic for sensitive skin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100999958B1 (en) * 2008-06-19 2010-12-09 주식회사 한국화장품제조 A cosmetic composition comprising an extract of Saxifraga caespitosa and a fabrication method of an extract of Saxifraga caespitosa

Similar Documents

Publication Publication Date Title
KR101932766B1 (en) Dendrobium chrysotoxum extract and its cosmetic use as an anti-aging agent
KR100478928B1 (en) Non-medicinal antioxidants containing sericin or sericin hydrolyzate as an active ingredient, cosmetics, food discoloration prevention, food, myocardial infarction, arteriosclerosis, diabetes treatment, cancer treatment, or stroke treatment
CA2827773A1 (en) Bioactive botanical cosmetic compositions and processes for their production
KR102354412B1 (en) Cosmetic Composition Comprising Lactobacillus Fermented product of Mixed Flower Extracts as Active Ingredient
KR102361109B1 (en) Preservative composition and extraction method of useful component using the same
JP2003113068A (en) Skin cosmetic
KR101848881B1 (en) Cosmetic composition for anti-wrinkle effect having fermented abeliophyllum distichum
KR102088728B1 (en) Cosmetic Composition for Improving Skin Elasticity and Winkles Comprising Plant Complex Extracts as Active Ingredient
US20060051439A1 (en) Antioxidant, skin preparation for external use, cosmetic and food
CN108567632B (en) Application of tea tree callus extract in skin care
KR101777836B1 (en) Anti-aging Composition Comprising Plant Stem Cell Derived from Cambium of Family Ginkgoaceae
KR102544792B1 (en) Composition Comprising Complex Extract of seaweeds Fermented by Lactobacillus Brevis with Anti-Wrinkling and Elasticity, Antioxidant, and Skin Hydration Property as Active Ingredient
KR101904215B1 (en) A composition for antioxidating and blocking ultraviolet comprising extracts of jujube seed
KR20020014453A (en) Ultraviolet-protecting cosmetic composition containing Saxifragaceae extracts
KR101227171B1 (en) Cosmetic composition using Apios and manufacturing method thereof
KR101656928B1 (en) Composition for protecting skin against UV light and wrinkle improvement comprising the extract of Polygonum viscoferum
JPH1029924A (en) Antiaging agent
KR101938801B1 (en) Lactobacillus sakei WiKim0066 with antioxidant and anti-aging effects
JP2006298812A (en) Antioxidant, skin lotion for anti-oxidization, elastase activity inhibitor and maillard reaction inhibitor
KR101937162B1 (en) Cosmetic composition for preventing uv-induced skin damage comprising the extract of solidago virgauea l. var coreana nakai
KR20160093427A (en) Cosmetic composition comprising the fermented extract of abeliophyllum distichum
KR102237543B1 (en) Method of Producing DNA Derived from Aloe Genus Plant, and Composition Containing DNA Derived from Aloe Genus Plant for Anti-Aging and Anti-Inflammation
US6806070B1 (en) Use of bacterial extracts of the pseudomonadaceae family as cosmetic agents
KR101957435B1 (en) Method for preparing extract of fermented silkworm cocoon for improving antiwrinkle and a cosmetic composition containing the fermented extract of silkworm cocoon as an active ingredients
KR101740373B1 (en) Composition for improving skin containing callus of Broussonetia plant

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
E902 Notification of reason for refusal
E601 Decision to refuse application